SCHEMBL1473973

SCHEMBL1473973

NC(=S)NC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1475935 0.88
SCHEMBL2257067 0.88
SCHEMBL16109065 0.87 EPHX1 (0.47)
SCHEMBL27720256 0.87 EPHX1 (0.47)
SCHEMBL1605352 0.86 ALDH1A1 (0.64)
SCHEMBL1605115 0.86 ALDH1A1 (0.64)
SCHEMBL1528011 0.86 ALDH1A1 (0.64)
SCHEMBL8739516 0.86 ALDH1A1 (0.64)
SCHEMBL5131730 0.85 SMN1; SMN2 (0.39)
SCHEMBL17451776 0.85 KMT2A (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004101552-A1 OXAZOLIDINONE DERIVATIVES AS ANTIBACTERIAL AGENTS ORCHID CHEMICALS & PHARMACEUTICALS LTD (IN) 2004-11-25 WO claimed
US-20030055261-A1 Compounds with growth hormone releasing properties HELSINN THERAPEUTICS (U.S.), INC. 2003-03-20 US claimed
US-20030040483-A1 Compounds with growth hormone releasing properties HELSINN THERAPEUTICS (U.S.), INC. 2003-02-27 US claimed
US-6127391-A A PEPTIDE MIMETIC COMPOUND FOR STIMULATING THE RELEASE OF GROWTH HORMONE FROM THE PITUITARY NOVO NORDISK A/S (DK) 2000-10-03 US claimed
EP-0869974-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1998-10-14 EP claimed
WO-1997023508-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1997-07-03 WO claimed
US-20250206730-A1 THIAZOLE DERIVATIVE COMPOUND AND USES THEREOF AUTOTELIC BIO INC. (KR) 2025-06-26 US disclosed
WO-2025063816-A1 COMPOSITION FOR TREATING UTERINE FIBROSIS COMPRISING THIAZOLE DERIVATIVE COMPOUND 오토텔릭바이오 주식회사 2025-03-27 WO disclosed
WO-2025063819-A1 COMPOSITION FOR TREATING FIBROTIC DISEASE COMPRISING THIAZOLE DERIVATIVE COMPOUND 오토텔릭바이오 주식회사 2025-03-27 WO disclosed
WO-2025063820-A1 COMPOSITION FOR TREATING PULMONARY FIBROSIS COMPRISING THIAZOLE DERIVATIVE COMPOUND 오토텔릭바이오 주식회사 2025-03-27 WO disclosed
CN-112028825-B Tyrosine kinase inhibitor and pharmaceutical composition containing same 广东众生睿创生物科技有限公司 2025-03-14 CN disclosed
EP-4501928-A1 THIAZOLE DERIVATIVE COMPOUND AND USES THEREOF Autotelic Bio Inc. (KR) 2025-02-05 EP disclosed
CN-119255993-A Thiazole derivative compound and use thereof 奥托泰利克生物公司 2025-01-03 CN disclosed
EP-0397511-B1 Novel cephalosporin compounds and processes for preparation thereof LUCKY LTD (KR) 1996-09-04 EP disclosed
US-5541229-A ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS DR. KARL THOMAE GMBH (DE) 1996-07-30 US disclosed
US-5318992-A Administering for the treatment of hypotensive conditions and shock MERRELL DOW PHARMACEUTICALS INC. (US) 1994-06-07 US disclosed
US-5202315-A Antiboiotic LUCKY, LTD. (KR) 1993-04-13 US disclosed
WO-1992008721-A1 NOVEL CEPHALOSPORIN COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF LUCKY, LTD. (KR) 1992-05-29 WO disclosed
EP-0446699-A1 Inhibitors of nitric oxide biosynthesis MERRELL PHARMACEUTICALS INC. (US) 1991-09-18 EP disclosed
EP-0397511-A2 Novel cephalosporin compounds and processes for preparation thereof LUCKY, LTD. (KR) 1990-11-14 EP disclosed